(Q46226028)

English

Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes

scientific article published on 27 November 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19037628

Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19037628

type 2 diabetes

0 references

0 references

0 references

Jens Juul Holst

7

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19037628

8

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19037628

author name string

P V Højberg

1

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19037628

T Vilsbøll

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19037628

R Rabøl

3

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19037628

F K Knop

4

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19037628

M Bache

5

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19037628

T Krarup

6

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19037628

publication date

27 November 2008

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19037628

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19037628

52

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19037628

2

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19037628

199-207

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19037628

https://scigraph.springernature.com/pub.10.1007/s00125-008-1195-5

0 references

United Kingdom Prospective Diabetes Study 17: a 9-year update of a randomized, controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1007%2FS00125-008-1195-5

21 January 2018

The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta-cell function improved by supplementing basal insulin secretion in mild diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The defective glucose sensitivity of the B cell in non insulin dependent diabetes. Improvement after twenty hours of normoglycaemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma dipeptidyl peptidase-IV activity in patients with type-2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin and glucagon secretion are suppressed equally during both hyper- and euglycemia by moderate hyperinsulinemia in patients with diabetes mellitus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The influence of GLP-1 on glucose-stimulated insulin secretion: effects on beta-cell sensitivity in type 2 and nondiabetic subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Improvement of insulin secretion but not insulin resistance after short term control of plasma glucose in obese type II diabetics.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of control of blood glucose on plasma insulin responses to various stimuli in secondary failures to oral hypoglycemic agents and in newly diagnosed, maturity onset, ketosis-resistant diabetics.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antisera

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Similar elimination rates of glucagon-like peptide-1 in obese type 2 diabetic patients and healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secretion of the Incretin Hormones Glucagon-Like Peptide-1 and Gastric Inhibitory Polypeptide Correlates with Insulin Secretion in Normal Man Throughout the Day

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Near normalisation of blood glucose improves the potentiating effect of GLP-1 on glucose-induced insulin secretion in patients with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

On the physiology of GIP and GLP-1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diminished Immunoreactive Gastric Inhibitory Polypeptide Response to a Meal in Newly Diagnosed Type I (Insulin-Dependent) Diabetics*

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Nutrient, neural and endocrine control of glucagon-like peptide secretion

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and beta-cell function in type 2 diabetes: a parallel-group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The therapeutic actions of DPP-IV inhibition are not mediated by glucagon-like peptide-1.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The elimination rates of intact GIP as well as its primary metabolite, GIP 3-42, are similar in type 2 diabetic patients and healthy subjects.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Degradation of glucagon-like peptide-1 by human plasma in vitro yields an N-terminally truncated peptide that is a major endogenous metabolite in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reversal of islet GIP receptor down-regulation and resistance to GIP by reducing hyperglycemia in the Zucker rat

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatment.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Minireview: Secondary beta-cell failure in type 2 diabetes--a convergence of glucotoxicity and lipotoxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Banting lecture 1990. Beta-cells in type II diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced insulinotropic effect of gastric inhibitory polypeptide in first-degree relatives of patients with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gut hormones and diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Both GLP-1 and GIP are insulinotropic at basal and postprandial glucose levels and contribute nearly equally to the incretin effect of a meal in healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antidiabetogenic effect of glucagon-like peptide-1 (7-36)amide in normal subjects and patients with diabetes mellitus

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Defective amplification of the late phase insulin response to glucose by GIP in obese Type II diabetic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduced incretin effect in type 2 (non-insulin-dependent) diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of basal, but not of glucose-stimulated insulin secretion by human insulin in healthy and obese hyperinsulinemic subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance.

1 reference

https://pubmed.ncbi.nlm.nih.gov/19037628

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00125-008-1195-5

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19037628

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 December 2017

http://europepmc.org/abstract/MED/19037628

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46226028&oldid=2100479005"